ﻻ يوجد ملخص باللغة العربية
Objective: Chronic obstructive pulmonary disease (COPD) is a highly prevalent chronic condition. COPD is a major source of morbidity, mortality and healthcare costs. Spirometry is the gold standard test for a definitive diagnosis and severity grading of COPD. However, a large proportion of individuals with COPD are undiagnosed and untreated. Given the high prevalence of COPD and its clinical importance, it is critical to develop new algorithms to identify undiagnosed COPD, especially in specific groups at risk, such as those with sleep disorder breathing. To our knowledge, no research has looked at the feasibility of COPD diagnosis from the nocturnal oximetry time series. Approach: We hypothesize that patients with COPD will exert certain patterns and/or dynamics of their overnight oximetry time series that are unique to this condition. We introduce a novel approach to nocturnal COPD diagnosis using 44 oximetry digital biomarkers and 5 demographic features and assess its performance in a population sample at risk of sleep-disordered breathing. A total of n=350 unique patients polysomnography (PSG) recordings. A random forest (RF) classifier is trained using these features and evaluated using the nested cross-validation procedure. Significance: Our research makes a number of novel scientific contributions. First, we demonstrated for the first time, the feasibility of COPD diagnosis from nocturnal oximetry time series in a population sample at risk of sleep disordered breathing. We highlighted what digital oximetry biomarkers best reflect how COPD manifests overnight. The results motivate that overnight single channel oximetry is a valuable pathway for COPD diagnosis.
Pulmonary diseases impact millions of lives globally and annually. The recent outbreak of the pandemic of the COVID-19, a novel pulmonary infection, has more than ever brought the attention of the research community to the machine-aided diagnosis of
This work uses a data-driven approach to analyse how the resource requirements of patients with chronic obstructive pulmonary disease (COPD) may change, quantifying how those changes impact the hospital system with which the patients interact. This a
The diagnosis of heart diseases is a difficult task generally addressed by an appropriate examination of patients clinical data. Recently, the use of heart rate variability (HRV) analysis as well as of some machine learning algorithms, has proved to
We propose a hybrid sequential deep learning model to predict the risk of AMD progression in non-exudative AMD eyes at multiple timepoints, starting from short-term progression (3-months) up to long-term progression (21-months). Proposed model combin
This work introduces an integrative approach based on Q-analysis with machine learning. The new approach, called Neural Hypernetwork, has been applied to a case study of pulmonary embolism diagnosis. The objective of the application of neural hyper-n